Functional and Pharmacological Characterization of the Natriuretic Peptide-Dependent Lipolytic Pathway in Human Fat Cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 308, Issue 3, 2004, Pages 984-992

  Moro, Cedric ^a   Galitzky, Jean ^a   Sengenes, Coralie ^a   Crampes, François ^a,b   Lafontan, Max ^a   Berlan, Michel ^a,b  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

A 71915; ANANTIN; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; CYCLIC GMP; HS 142 1; INSULIN; ISOPRENALINE; PHENTOLAMINE MESYLATE; SERINE 28 TYROSINE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADRENERGIC SYSTEM; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENCY; DRUG POTENTIATION; HUMAN; HUMAN CELL; INCUBATION TIME; LIGAND BINDING; LIPOLYSIS; PRIORITY JOURNAL;

ADIPOCYTES; ADRENERGIC BETA-AGONISTS; ATRIAL NATRIURETIC FACTOR; BINDING SITES; HUMANS; ISOPROTERENOL; KINETICS; LIPOLYSIS; PEPTIDE FRAGMENTS; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ATRIAL NATRIURETIC FACTOR; TETRAHYDROISOQUINOLINES;

EID: 1342280965     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.060913     Document Type: Article

References (39)

1. Athanassopoulos GC and Dennis V (1991) Atrial natriuretic factor. Prog Cardiovasc Dis 33:313-328.
2. Berlin I, Deray G, Lechat P, Maistre G, Landault C, Chermat V, Brouard R, Ressayre C, and Puech AJ (1993a) Tertatolol potentiates exercise-induced atrial natriuretic peptide release by increasing atrial diameter in healthy subjects. Cardiology 83:16-24.
3. Berlin I, Lechat P, Deray G, Landault C, Maistre G, Chermat V, Brouard R, Ressayre C, and Puech AJ (1993b) β-Adrenoceptor blockade potentiates acute exercise-induced release of atrial natriuretic peptide by increasing atrial diameter in normotensive healthy subjects. Eur J Clin Pharmacol 44:127-133.
4. Bradley DC and Kaslow HR (1989) Radiometric assays for glycerol, glucose and glycogen. Anal Biochem 180:11-16.
5. Bulow J (1981) Human adipose tissue blood flow during prolonged exercise, III. Effect of beta-adrenergic blockade, nicotinic acid and glucose infusion. Scand J Clin Lab Investig 41:415-424.
6. Carey GB (1998) Mechanisms regulating adipocyte lipolysis. Adv Exp Med Biol 441:157-170.
7. Carvajal J, Aguan K, Thompson L, Buhimschi I, and Weiner C (2001) Natriuretic peptide-induced relaxation of myometrium from the pregnant guinea pig is not mediated by guanylate cyclase activation. J Pharmacol Exp Ther 297:183-188.
8. Cosenzi A, Sacerdote A, Bocin E, Molino R, Mangiarotti M, and Bellini G (1995) Metabolic effects of atenolol and doxazosin in healthy volunteers during prolonged physical exercise. J Cardiovasc Pharmacol 25:142-146.
9. Delporte C, Winand J, Poloczek P, Von Geldern T, and Christophe J (1992) Discovery of a potent atrial natriuretic peptide antagonist for ANP-A receptors in the human neuroblastoma NB-OK-1 cell line. Eur J Pharmacol 224:183-188.
10. Galitzky J, Sengenes C, Thalamas C, Marques MA, Senard JM, Lafontan M, and Berlan M (2001) The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J Lipid Res 42:536-544.
11. Hellstrom L, Blaak E, and Hagstrom-Toft E (1996) Gender differences in adrenergic regulation of lipid mobilization during exercise. Int J Sports Med 17:439-447.
12. Huang W, Lee M, Perng H, Yang SP, Kuo SW, and Chang H (2002) Circulating brain natriuretic peptide values in healthy men before and after exercise. Metabolism 51:1423-1426.
13. Kalra P and Tigas S (2002) Regulation of lipolysis: natriuretic peptides and the development of cachexia. Int J Cardiol 85:125-132.
14. Kjaer M, Secher NH, and Galbo H (1987) Physical stress and catecholamine release. Bailliere's Clin Endocrinol Metab 1:279-298.
15. 2-adrenoceptors: the regulation of fat cell function and lipolysis. Endocr Rev 16:716-738.
16. Levin E, Gardner D, and Samson W (1998) Natriuretic peptides. N Engl J Med 339:321-328.
17. Londos C, Brasaemle DL, Schultz CJ, Adler-Wailes DC, Levin DM, Kimmel AR, and Rondinone CM (1999) On the control of lipolysis in adipocytes. Ann NY Acad Sci 892:155-168.
18. Minamitake Y, Furuya M, Kitajima Y, Takehisa M, and Tanaka S (1990) Synthesis and biological property of α-human atrial natriuretic peptide analogs with a constrained or stereochemically modified cyclic moiety. Chem Pharm Bull (Tokyo) 38:1920-1926.
19. Moberg E, Enoksson S, and Hagstrom-Toft E (1998) Importance of phosphodiesterase 3 for the lipolytic response in adipose tissue during insulin-induced hypoglycemia in normal man. Horm Metab Res 30:684-688.
20. Morishita Y, Sano T, Ando K, Saitoh Y, Kase H, Yamada K, and Matsuda Y (1991) Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptor. Biochem Biophy Res Commun 176:949-957.
21. Moro C, Galitzky J, Sengenes C, Crampes F, De Glisezinski I, Thalamas C, Lafontan M, and Berlan M (2003) Evidence for a non-adrenergic lipolysis in human subcutaneous adipose tissue during exercise: putative role of natriuretic peptides (Abstract). Fundam Clin Pharmacol 17:244.
22. Nachshon S, Zamir O, Matsuda Y, and Zamir N (1995) Effects of ANP receptor antagonists on ANP secretion from adult rat cultured atrial myocytes. Am J Physiol 268:428-432.
23. Ogawa Y and Kazuwa N (1995) Brain natriuretic peptide as a cardiac hormone in cardiovascular disorders. Hypertens Pathophysiol Diagn Manage 48:833-839.
24. Ohba H, Takada H, Musha H, Nagashima J, Mori N, Awaya T, Omiya K, and Murayama M (2001) Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men. Am Heart J 141:751-758.
25. Poirier H, Labrecque J, Deschenes J, and Delean A (2002) Allotopic antagonism of the non-peptide atrial natriuretic peptide (ANP) antagonist HS-142-1 on natriuretic peptide receptor NPR-A. Biochem J 362:231-237.
26. Richards A, Lainchbury J, Nicholls M, Cameron A, and Yandle T (2002) Dendroaspis natriuretic peptide: endogenous or dubious? Lancet 359:5-6.
27. Rodbell M (1964) Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380.
28. Rotem R, Zamir N, Keynan N, Barkan D, Breitbart H, and Naor Z (1998) Atrial natriuretic peptide induces acrosomal exocytosis of human spermatozoa. Am J Physiol 274:E218-E223.
29. Sengenes C, Berlan M, De Glisezinski I, Lafontan M, and Galitzky J (2000) Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 14:1345-1351.
30. Sengenes C, Bouloumie A, Hauner H., Berlan M, Busse R, Lafontan M, and Galitzky J (2003) Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem 278:48617-48626.
31. Sengenes C, Stich V, Berlan M, Hejnova J, Lafontan M, Pariskova Z, and Galitzky J (2002a) Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women. Int J Obes Relat Metab Disord 26:24-32.
32. Sengenes C, Zakaroff-Girard A, Moulin A, Berlan M, Bouloumie A, Lafontan M, and Galitzky J (2002b) Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity. Am J Physiol Regul Integr Comp Physiol 283:R257-R265.
33. Stallknecht B, Lorentsen J, Enevoldsen LH, Bulow J, Biering-Sorensen F, Galbo H, and Kjaer M (2001) Role of the sympathoadrenergic system in adipose tissue metabolism during exercise in humans. J Physiol (Lond) 536:283-294.
34. 2-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects. Am J Physiol Regul Integr Comp Physiol 279:R499-R504.
35. 2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic-euglycemic clamp in men. Am J Physiol Endocrinol Metab 285:E599-E607.
36. Von Geldern T, Budzik G, Dillon T, Holleman W, Holst M, Kiso Y, Novosad E, Opgenorth T, Rockway T, Thomas A, and Yeh S (1990) Atrial natriuretic peptide antagonists: biological evaluation and structural correlations. Mol Pharmacol 38:771-778.
37. Weber W, Fischli W, Hochuli E, Kupfer E, and, Weibel E (1991) Anantin-a peptide antagonist of the atrial natriuretic factor (ANF). I. Producing organism, fermentation, isolation and biological activity. J Antibiot (Tokyo) 44:164-171.
38. Wyss D, Lahm H, Manneberg B, and Labhardt A (1991) Anantin-a peptide antagonist of the atrial natriuretic factor (ANF). II. Determination of the primary sequence by NMR on the basis of proton assignments. J Antibiot (Tokyo) 44:172-180.
39. Zamir N, Barkan D, Keynan N, Naor Z, and Breitbart H (1995) Atrial natriuretic peptide induces acrosomal exocytosis in bovine spermatozoa. Am J Physiol 269:216-221.